Description |
Product Type |
Product Size |
Capsules |
20'S |
Product Company |
Brookes Pharmaceutical |
Diclofenac sodium 100mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Asian Continental |
Diclofenac Sodium 75mg |
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Shaigen Pharmaceuticals |
Meloxicam 7.5mg |
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Mass Pharma |
Amlodipine 5mg
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Injection
|
6'S |
Product Company |
Chiesi Pharmaceuticals |
Meglumine indomethicinate 77.2+50mg
|
Content | The Sustain Release tablet form of diclofenac is used to reduce pain, swelling (inflammation), and joint stiffness from arthritis. | Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).Label NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. | Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis.
| Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
| Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Indomethacin is an anti-inflammatory agent, used to combat pain and inflammation in various conditions
|
Reviews
There are no reviews yet.